Trial intelligence / Profile preview

Lithium Mouthwash for Prevention and Treatment of Radiation-Induced Oral Mucositis and Dysgeusia

ChiCTR2400082557Phase 2Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Apr 2024
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of lithium in oral mucositis (OM), dysgeusia and xerostomia (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Oral mucositis severity and Taste function. Started Apr 2024; status: recruiting.

02

Drugs

lithium
03

Conditions

oral mucositis (OM)dysgeusiaxerostomia

Beyond the preview

Go deeper on ChiCTR2400082557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400082557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call